<DOC>
	<DOCNO>NCT01556360</DOCNO>
	<brief_summary>The purpose study describe bone status patient genetic hemochromatosis , diagnostic time evolution treatment .</brief_summary>
	<brief_title>Bone Status Patients With Genetic Hemochromatosis : 3 Years Descriptive Evolutionary Study</brief_title>
	<detailed_description>Bone diseases recognize recently complication genetic hemochromatosis . Further study need describe role iron bone injury . The purpose study describe bone status patient genetical hemochromatosis , diagnostic time evolution treatment .</detailed_description>
	<mesh_term>Hemochromatosis</mesh_term>
	<criteria>Patients 18 80 year C282 homozygosity corticosteroid last 3 month follow treatment last 6 month : anabolic steroid , growth hormone , hormone therapy menopause , tibolone , raloxifene . follow treatment inclusion last 6 month : teriparatide , parathormone , fluor , strontium ranelate , biphosphonate . cancer evolutionary hemopathy ( include monoclonal gammopathy ) pregnancy inclusion time treat osteoporosis patient wich follow seem hard inclusion another study incompatible one</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>genetic hemochromatosis</keyword>
	<keyword>Iron overload</keyword>
	<keyword>C282 homozygosity</keyword>
</DOC>